JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Khan, W. A.
Right arrow Articles by Mukhtar, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Khan, W. A.
Right arrow Articles by Mukhtar, H.

Epidermal cytochrome P-450: immunochemical characterization of isoform induced by topical application of 3-methylcholanthrene to neonatal rat

WA Khan, SS Park, HV Gelboin, DR Bickers and H Mukhtar

Department of Dermatology, Case Western Reserve University, Cleveland, Ohio.

To further define the capacity of skin to metabolize various drugs and carcinogens by the cytochrome P-450 (P-450)-dependent monooxygenase, we studied the profile of P-450 isoform(s) in neonatal rat epidermis after application of 3-methylcholanthrene (3-MC) to skin. Highly specific monoclonal antibodies (MAbs) 2-66-3 and 1-7-1 against purified rat liver P-450 isoforms b and c induced by phenobarbital and 3-MC, respectively, were used. After a single topical application of 3-MC to rats aryl hydrocarbon hydroxylase (AHH), 7-ethoxycoumarin-O-deethylase and 7-ethoxyresorufin-O-deethylase activities in epidermal microsomes were induced significantly. Radioimmunoassay of epidermal microsomes from untreated control animals with 35S-labeled MAb-2-66-3 showed significant binding whereas negligible binding with MAb 1-7-1 was observed. On the other hand significant binding was observed with 35S- labeled MAb 1-7-1 with epidermal microsomes prepared from 3-MC-treated animals. Histochemical staining of epidermis from control animals showed no immunoreactivity with either MAb 1-7-1 or MAb 2-66-3 whereas epidermis obtained from 3-MC-treated rats showed significant immunoreactivity with MAb 1-7-1. Western blot analysis of epidermal microsomes prepared from control animals showed no immunoreactivity with either MAb 1-7-1 or 2-66-3 whereas epidermal microsomes prepared from 3-MC-treated animals showed distinct immunoreactivity with MAb 1-7- 1. MAb 2-66-3 inhibited AHH and 7-ethoxycoumarin-O-deethylase activity (40-50%) in microsomes prepared from control animals.(ABSTRACT TRUNCATED AT 250 WORDS)

Volume 249, Issue 3, pp. 921-927, 06/01/1989
Copyright © 1989 by American Society for Pharmacology and Experimental Therapeutics







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1989 by the American Society for Pharmacology and Experimental Therapeutics.